Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Anticoagulant reduces clot risk after surgery

  • Comment

A daily 220mg dose of the oral anticoagulant dabigatran etexilate is at least as effective as a daily 40mg injection of enoxaparin in preventing venous thromboembolism after total hip replacement surgery, according to latest research.

International researchers, who studied 2,055 patients who had undergone total hip replacement, said that dabigatran etexilate “significantly reduced” the number of major blood clots and deaths from blood clots when compared to enoxaparin.

The full study results were presented at last week’s European Haematology Association annual conference in Barcelona, Spain.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.